Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Does Preschool Boost Kids' Long-Term Academic Success? Study Finds Mixed Results

FRIDAY, May 3, 2024 -- Pre-kindergarten programs have long been considered an early ticket to future success for children.But the evidence is much more mixed...

AI Might Spot Rare Diseases in Patients Years Earlier

FRIDAY, May 3, 2024 -- Artificial intelligence might be able to identify patients who have rare diseases years earlier than they would typically be diagnosed...

An Orangutan Healed Himself With Medicinal Plant

FRIDAY, May 3, 2024 -- Primates are capable of tending to wounds using medicinal plants, a new case report says.A male Sumatran orangutan treated a facial...

Quit-Smoking Meds Not Working for You? Try Upping the Dose

FRIDAY, May 2, 2024 -- Folks struggling to quit smoking might need a bump up on the dose of medication they’re using to help them stop, according to new c...

Fewer Americans Are Suffering Most Dangerous Form of Heart Attack

FRIDAY, May 3, 2024 -- Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says.STEMI (ST‐segment-elevation m...

About 56 Percent of Pregnant Smokers Quit During Pregnancy

THURSDAY, May 2, 2024 -- More than half of women who smoke before pregnancy quit while pregnant, according to research published in the May 2 issue of the...

Report Details Nonfatal Traffic-Related Pedestrian Injuries Presenting to the ED

THURSDAY, May 2, 2024 -- The overall visit proportion for emergency department visits involving pedestrian injury is 45.62 per 100,000 emergency department...

CDC: Decrease in Maternal Mortality Rates Seen in 2022

THURSDAY, May 2, 2024 -- In 2022, there was a decrease in maternal mortality rates, according to a report published in the May Health E-Stats, a publication of...

Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer

THURSDAY, May 2, 2024 -- For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical...

Algorithm From EHR Can ID Common Variable Immunodeficiency Disease

THURSDAY, May 2, 2024 -- A machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health...

Neurocrine Biosciences Announces U.S. FDA Approval of Ingrezza Sprinkle (valbenazine) Capsules

SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved...

FDA Approves Libervant (diazepam) Buccal Film for the Treatment of Seizure Clusters in Pediatric Patients Ages 2-5 Years

WARREN, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a...

FDA Approves Xolremdi (mavorixafor) for Use in Patients with WHIM Syndrome

BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune...

FDA Grants Full Approval for Tivdak to Treat Recurrent or Metastatic Cervical Cancer

NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE) April 29, 2024 -- Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and...

FDA Approves Hercessi (trastuzumab-strf), a Biosimilar to Herceptin

DURHAM, N.C., April 29, 2024 /PRNewswire/ -- Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of...

Abeona Therapeutics Provides Regulatory Update on Pz-cel

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...

Supernus Provides Regulatory Update for SPN-830

ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome

NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer

DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a...

Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer

2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...

Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism

Lyon, France, and Cambridge, MA, May 2, 2024 — Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and...

Gilgamesh Announces Initiation of Phase 2a Trial of GM-1020 in Major Depressive Disorder

NEW YORK, May 1, 2024. Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for...

Scientists Discover How an Essential Nutrient Enters the Brain

May 1, 2024 -- Researchers have discovered that choline, an essential nutrient vital for brain health, is actively transported from the bloodstream into the...

NRx Pharmaceuticals Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

RADNOR, Pa., April 30, 2024, NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals", the "Company"), a clinical stage pharmaceutical company today that its...

Ingenium Therapeutics Novel NK Cell Therapy IGNK001 Receives Orphan Drug Designation From FDA

DAEJEON, Korea, April 30, 2024 /PRNewswire/ -- Ingenium Therapeutics, a leading innovator in next-generation NK cell therapies, announced today that its...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.